404 related articles for article (PubMed ID: 33979674)
21. Redox Control of the Dormant Cancer Cell Life Cycle.
Li B; Huang Y; Ming H; Nice EC; Xuan R; Huang C
Cells; 2021 Oct; 10(10):. PubMed ID: 34685686
[TBL] [Abstract][Full Text] [Related]
22. A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer.
Korentzelos D; Clark AM; Wells A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33022920
[TBL] [Abstract][Full Text] [Related]
23. The role of tumor microenvironment and exosomes in dormancy and relapse.
Attaran S; Bissell MJ
Semin Cancer Biol; 2022 Jan; 78():35-44. PubMed ID: 34757184
[TBL] [Abstract][Full Text] [Related]
24. Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse.
Lim AR; Ghajar CM
Semin Cancer Biol; 2022 Jan; 78():104-123. PubMed ID: 33979673
[TBL] [Abstract][Full Text] [Related]
25. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.
Li WJ; Wang Y; Liu R; Kasinski AL; Shen H; Slack FJ; Tang DG
Front Cell Dev Biol; 2021; 9():640587. PubMed ID: 33763422
[TBL] [Abstract][Full Text] [Related]
27. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
Muzes G; Sipos F
Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
[TBL] [Abstract][Full Text] [Related]
28. Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways.
Manjili MH; Khazaie K
Semin Cancer Biol; 2022 Jan; 78():1-4. PubMed ID: 34990835
[TBL] [Abstract][Full Text] [Related]
29. Cancer stem cells: the promise and the potential.
Ajani JA; Song S; Hochster HS; Steinberg IB
Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
[TBL] [Abstract][Full Text] [Related]
30. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
31. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion.
D'Alterio C; Scala S; Sozzi G; Roz L; Bertolini G
Semin Cancer Biol; 2020 Feb; 60():351-361. PubMed ID: 31454672
[TBL] [Abstract][Full Text] [Related]
33. Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State.
Manjili MH
Cancer Res; 2017 May; 77(10):2564-2569. PubMed ID: 28507050
[TBL] [Abstract][Full Text] [Related]
34. When dormancy fuels tumour relapse.
Santos-de-Frutos K; Djouder N
Commun Biol; 2021 Jun; 4(1):747. PubMed ID: 34135460
[TBL] [Abstract][Full Text] [Related]
35. Targeting Cancer Cell Dormancy.
Recasens A; Munoz L
Trends Pharmacol Sci; 2019 Feb; 40(2):128-141. PubMed ID: 30612715
[TBL] [Abstract][Full Text] [Related]
36. The clinical and therapeutic implications of cancer stem cell biology.
Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
[TBL] [Abstract][Full Text] [Related]
37. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
38. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
[TBL] [Abstract][Full Text] [Related]
39. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
40. The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment.
Ma B; Wells A; Clark AM
Semin Cancer Biol; 2020 Feb; 60():138-147. PubMed ID: 31376430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
